[HTML][HTML] From interaction to intervention: how mesenchymal stem cells affect and target triple-negative breast cancer
Triple-negative breast cancer (TNBC) lacks estrogen receptor, progesterone receptor, and
human epidermal growth factor receptor 2 expressions, making targeted therapies …
human epidermal growth factor receptor 2 expressions, making targeted therapies …
[HTML][HTML] Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma
V Coccè, M Bonelli, S La Monica, R Alfieri… - Biochemical …, 2023 - Elsevier
Malignant pleural mesothelioma is an asbestos-related tumor originating in mesothelial cells
of the pleura that poorly responds to chemotherapeutic approaches. Adult mesenchymal …
of the pleura that poorly responds to chemotherapeutic approaches. Adult mesenchymal …
[HTML][HTML] Edaravone: A Novel Possible Drug for Cancer Treatment?
Despite significant advancements in understanding the causes and progression of tumors,
cancer remains one of the leading causes of death worldwide. In light of advances in cancer …
cancer remains one of the leading causes of death worldwide. In light of advances in cancer …
[HTML][HTML] Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer
N Eiro, M Fraile, S Escudero-Cernuda… - Stem Cell Research & …, 2024 - Springer
Background Triple-negative breast cancer (TNBC) is the most lethal subtype of breast
cancer and, despite its adverse effects, chemotherapy is the standard systemic treatment …
cancer and, despite its adverse effects, chemotherapy is the standard systemic treatment …
[HTML][HTML] Anticancer platinum-drug delivered by mesenchymal stromal cells improves its activity on glioblastoma
V Coccè, E Martegani, L Doneda, I Rimoldi… - Cancer …, 2024 - Springer
Background Glioblastoma multiforme (GBM) is nowadays the most aggressive tumor
affecting brain in adults with a very poor prognosis due to the limited therapies and the …
affecting brain in adults with a very poor prognosis due to the limited therapies and the …
Impregnation of mesenchymal stem cell secretome with Wortmannin inhibits the proliferation of breast cancer cells via PI3K/Akt/mTOR pathway
DF Ismail, MM El-Keey, SM Elgendy, M Hessien - 2024 - researchsquare.com
The utilization of Mesenchymal stem cells (MSCs)-derived secretome was suggested as a
promising alternative in cell-based regenerative therapy. Herein, the MSCs cells were …
promising alternative in cell-based regenerative therapy. Herein, the MSCs cells were …